AI-Driven Health Management Revolution: From Reactive Delayed Intervention to Proactive Real-Time Prevention – Full-Chain Innovation Showcased at China Innovative Healthcare Assets Salon | Deal Roundtable Episode 19

In recent years, a new wave of AI technologies, represented by generative AI and large language models, has swept across various sub-sectors of healthcare and medical services, reaching the stage of value realization in 2025. Meanwhile, driven by multiple factors including policy guidance, growing market demand, and enhanced product capabilities, the health management sector has ushered in a period of explosive growth, becoming the primary application scenario for the deployment of AI technologies in healthcare.

The integrated development of both is highly anticipated and raises intriguing questions: What qualitative changes has the new wave of technology brought to health management? Whether targeting businesses (2B/H) or consumers (2C), what is the optimal development path for AI-driven health management? Which niche sectors represent the most promising application scenarios for AI in health management? And how can the ideal payer be identified?

Against this backdrop, the 19th session of the "China Innovative Medical Assets Living Room" Trading Roundtable, co-hosted by VCBeat and Weijieyao at 15:00 on Monday, March 30, has invitedLi Jiaming, Deputy General Manager of Lejian Health Technology Group; Wu Lei, AI R&D Director of Huamei HaolianTwo guests centered around《AI Reconstructs Health Management: Full-Chain Innovation from Passive Delayed Intervention to Proactive Instant Prevention》Topic Discussion: Sharing Challenges and Breakthroughs in AI Healthcare, and Outlook on Future Trends.